{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:01:23Z","timestamp":1792695683422,"version":"4.5.0"},"reference-count":45,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2012,7,26]],"date-time":"2012-07-26T00:00:00Z","timestamp":1343260800000},"content-version":"vor","delay-in-days":8061,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[1990,7]]},"abstract":"<jats:p>1. Single doses (10, 30 and 100 mg) of atipamezole (MPV\u20101248), a new potent and selective imidazole\u2010type alpha 2\u2010adrenoceptor antagonist, and saline placebo were administered as 20 min intravenous infusions to six healthy male volunteers in a randomized double\u2010blind, cross\u2010over phase I study. Later, 100 mg atipamezole was given orally to the same subjects in an open fashion. 2. The i.v. doses resulted in linearly dose\u2010related concentrations of atipamezole in plasma. Pharmacokinetic calculations revealed an elimination half\u2010life of 1.7\u20102.0 h, an apparent volume of distribution of 3.0\u20103.5 l kg\u20101 and a total plasma clearance of 1.1\u20101.5 l h\u20101 kg\u20101. No atipamezole could be detected in plasma after oral dosing. 3. Subjective drug effects were seen mainly after the largest i.v. dose and included increased alertness and nervousness, coldness and sweating of hands and feet, tremor and shivering, motor restlessness, and increased salivation. Salivation was also quantitated using dental cotton rolls, with dose\u2010related increases produced by the i.v. doses. 4. The 100 mg i.v. dose increased plasma noradrenaline concentrations on average by 484 +\/\u2212 269 (s.d.)%, and also elevated both systolic and diastolic blood pressure (mean increases 17 +\/\u2212 7\/14 +\/\u2212 2 mm Hg). The 30 mg dose had minor and the 10 mg dose no effects on these variables. Adrenaline and cyclic AMP levels in plasma were increased only after the largest dose. No drug effects were observed after oral dosing. 4. Plasma C\u2010peptide and blood glucose levels were not markedly influenced by the drug, and cortisol secretion was not stimulated. 5. The observed effects are compatible with the presumed alpha 2\u2010adrenoceptor antagonistic action of atipamezole and are in general concordance with the reported results of other alpha 2\u2010 adrenoceptor antagonists (yohimbine and idazoxan). 6. Although not orally active, atipamezole may prove to be a useful agent in studies of alpha 2\u2010adrenoceptor function in man.<\/jats:p>","DOI":"10.1111\/j.1365-2125.1990.tb03748.x","type":"journal-article","created":{"date-parts":[[2012,7,27]],"date-time":"2012-07-27T00:33:26Z","timestamp":1343349206000},"page":"97-106","source":"Crossref","is-referenced-by-count":55,"title":["Pharmacological effects and pharmacokinetics of atipamezole, a novel alpha 2\u2010adrenoceptor antagonist\u2010a randomized, double\u2010blind cross\u2010over study in healthy male volunteers."],"prefix":"10.1111","volume":"30","author":[{"given":"S","family":"Karhuvaara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Kallio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Scheinin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Anttila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JS","family":"Salonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Scheinin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,7,26]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2044-8341.1974.tb02285.x"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365518509155233"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1985.tb05124.x"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198500076-00027"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1042\/cs068s137"},{"key":"e_1_2_1_7_1","first-page":"600","article-title":"Alpha\u20102A and alpha\u20102B adrenergic receptor subtypes: Antagonist binding in tissues and cell lines containing only one subtype","volume":"245","author":"Bylund D. B.","year":"1988","journal-title":"J. Pharmac. exp. Ther."},{"key":"e_1_2_1_8_1","first-page":"85","volume-title":"Recent advances in receptor chemistry","author":"Chapleo C. B.","year":"1988"},{"key":"e_1_2_1_9_1","volume-title":"Abstract 1724P","author":"Crossley D. I.","year":"1984"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1983.tb08809.x"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1984.161"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1984.tb02332.x"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1139\/y87-093"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1201\/b14095"},{"key":"e_1_2_1_15_1","first-page":"143","article-title":"Yohimbine: a pharmacological probe for study of the \u03b12\u2010adrenoceptor","volume":"35","author":"Goldberg M. R.","year":"1983","journal-title":"Pharmac. Rev."},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(79)90136-5"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198812000-00001"},{"issue":"527","key":"e_1_2_1_18_1","first-page":"25","article-title":"Differentiated sympathetic activation during mental stress evoked by the Stroop test","author":"Hjemdahl P.","year":"1984","journal-title":"Acta Physiol. Scand."},{"key":"e_1_2_1_19_1","first-page":"55","volume-title":"Pharmacology of antihypertensive drugs","author":"Hoefke W.","year":"1980"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(00)84408-4"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1989.103"},{"key":"e_1_2_1_22_1","first-page":"633","article-title":"Tolerability and effects of atipamezole, a novel alpha2\u2010adrenoceptor antagonist, in healthy male volunteers. An open dose\u2010finding study","volume":"45","author":"Karhuvaara S.","year":"1989","journal-title":"Curr. Ther. Res."},{"key":"e_1_2_1_23_1","unstructured":"Karjalainen A. Virtanen R.&Karjalainen A.(1986).Synthesis of 4(5)\u2010(2 3\u2010dihydro\u20101H\u2010inden\u20102\u2010yl)imidazoles a novel class of potent \u03b12\u2010adrenoceptor antagonists.IX Int. Symp. on Med. Chem. Berlin p268."},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.35.10.1085"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780030211"},{"key":"e_1_2_1_26_1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0031-6997(25)06843-7","article-title":"Presynaptic regulation of the release of catecholamines","volume":"32","author":"Langer S. Z.","year":"1981","journal-title":"Pharmac. Rev."},{"key":"e_1_2_1_27_1","first-page":"151","volume-title":"Psychopharmacology\u2014The third generation of progress","author":"Langer S. Z.","year":"1987"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1018717"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198707000-00001"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-198807000-00003"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.2337\/diab.27.5.554"},{"key":"e_1_2_1_32_1","volume-title":"PCNONLIN (version 3.0), Software for the Statistical Analysis of Nonlinear Models on Micros","author":"Metzler C. M.","year":"1989"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02395201"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00498572"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-67-5-1054"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1986.01800090035006"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(85)90416-9"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1981.tb01217.x"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4612-4596-4_5"},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00647832"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(88)90689-9"},{"key":"e_1_2_1_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1987.tb03196.x"},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1987.tb03224.x"},{"key":"e_1_2_1_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1985.tb01114.x"},{"key":"e_1_2_1_45_1","first-page":"190","article-title":"Highly selective and specific antagonism of central and peripheral \u03b12\u2010adrenoceptors by atipamezole","volume":"297","author":"Virtanen R.","year":"1988","journal-title":"Arch. int. Pharmacodyn. Ther."},{"key":"e_1_2_1_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1989.113"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2125.1990.tb03748.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2125.1990.tb03748.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T14:50:58Z","timestamp":1743864658000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2125.1990.tb03748.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,7]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1990,7]]}},"alternative-id":["10.1111\/j.1365-2125.1990.tb03748.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2125.1990.tb03748.x","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,7]]}}}